DECREASED EMBRYO VIABILITY

This adverse event was reported 24 times

These drugs are most commonly taken by patients reporting DECREASED EMBRYO VIABILITY:

# Drug Count
0 CERTOLIZUMAB PEGOL 4
1 CHORIOGONADOTROPIN ALFA 3
2 METFORMIN 3
3 METFORMIN ER 500 MG 3
4 METFORMIN ER 750 MG 3
5 PROGESTERONE 3
6 CABERGOLINE 2
7 ESTRADIOL 2
8 MONTELUKAST 2
9 NATALIZUMAB 2
See all common drugs associated with DECREASED EMBRYO VIABILITY

DECREASED EMBRYO VIABILITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ESTRADIOL VALERATE 1 0.0013
1 CHORIOGONADOTROPIN ALFA 3 0.0011
2 SELENIUM SULFIDE 1 0.0011
3 CABERGOLINE 2 0.0004
4 RALTEGRAVIR 1 0.0002
5 PROGESTERONE 3 0.0001
6 THEOPHYLLINE ANHYDROUS 1 0.0001
7 KETOCONAZOLE FOAM 1 0.0001
8 KETOCONAZOLE CREAM, 2% 1 0.0001
9 MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE 1 0.0001
See all drugs enriched for association with DECREASED EMBRYO VIABILITY

DECREASED EMBRYO VIABILITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Gonadotropin [EPC] 2 0.0009
1 Ergot Derivative [EPC] 2 0.0004
2 Progesterone [EPC] 3 0.0001
3 Leukotriene Receptor Antagonist [EPC] 1 0.0000
4 Methylxanthine [EPC] 1 0.0000
5 Estrogen [EPC] 2 0.0000
6 Aminosalicylate [EPC] 1 0.0000
7 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
8 Azole Antifungal [EPC] 1 0.0000
9 Progestin [EPC] 1 0.0000
See all drug classes enriched for association with DECREASED EMBRYO VIABILITY